Diabetes drug Ozempic will cost half-price for US patients paying cash
Ozempic price slashed following Donald Trump’s demand
- Novo Nordisk is making its popular diabetes drug Ozempic available to American patients for $499 per month, roughly half its standard price, provided they pay in cash.
- Ozempic, scientifically known as semaglutide, is also sold as the weight-loss medication Wegovy and has significantly transformed diabetes and obesity treatments globally.
- The price reduction comes after Donald Trump criticised the high cost of GLP-1 agonists in the US, claiming he would drastically cut prescription drug prices.
- Trump has previously accused European nations of unfairly burdening American patients with drug costs due to their healthcare systems' bargaining power.
- While pharmaceutical companies are exploring ways to lower drug prices, Trump's proposed tariffs could potentially increase the cost of US drugs manufactured abroad.